The Global Blood Lancets Market size is expected to reach $1.5 billion by 2025, rising at a market growth of 8.5% CAGR during the forecast period. A blood lancet is described as a scalpel-like medical device which has a double-edged blade. The blade is used to pierce the skin to collect blood samples that are further used to diagnose multiple diseases such as hyperlipidemia of diabetes and dyslipidemia. Diabetic patients use these lancets regularly to track their blood glucose levels. A blood lancet is a portable medical device used for the collection of capillary blood. Furthermore, blood lancets find their uses in-home healthcare as well as in hospitals or pathology laboratories to confirm the blood group of individuals.
The major factors driving the growth of the blood lancets market include a significantly increased prevalence of chronic diseases like diabetes, hyperlipidemia, and dyslipidemia and increased inclination toward home care diagnostics. Additionally, the rise in the use of disposable blood lancets for painless diagnosis of blood sugar levels, hemoglobin, lipid levels, and other important blood components accelerates the growth of the industry.
Disposable lancet eliminates the risk of blood transfusion and transmission of infections and thus contributes to the growth of the blood lancets industry. Nevertheless, low awareness in developed countries about homecare lancet is expected to hamper the market growth. On the contrary, the favorable regulatory scenario is having a positive effect on the growth of the blood lancets market, thereby generating lucrative opportunities in the near future.
Recently, emerging and re-emerging infectious diseases like coronavirus disease poses a significant threat to public health in countries across the globe. Infectious diseases are the number one cause of morbidity and mortality worldwide. Diagnostics is the first step to treating infectious diseases and eradicating them. There is an urgent need to identify appropriate diagnostic strategies for better treatment of each disease due to the ever-evolving pathogens and emerging new diseases. In addition, effective diagnostic techniques are essential for disease identification and better treatment, as well as population outbreak control.
Based on Type, the market is segmented into Vacuum Blood Lancets, Safety Blood Lancets and Standard Blood Lancets. Based on End Users, the market is segmented into Homecare, Hospitals and Clinics, Blood Banks and other End Users. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Medtronic PLC, Abbott Laboratories, Terumo Corporation, Haemonetics Corporation, Nipro Corporation, Sarstedt AG & Company, F.L. Medical S.r.l., Socorex Isba SA, and PL Medical Co., LLC
Scope of the Study
Market Segmentation:
By Type
By End Users
By Geography
Companies Profiled
Unique Offerings from the Publisher
The major factors driving the growth of the blood lancets market include a significantly increased prevalence of chronic diseases like diabetes, hyperlipidemia, and dyslipidemia and increased inclination toward home care diagnostics. Additionally, the rise in the use of disposable blood lancets for painless diagnosis of blood sugar levels, hemoglobin, lipid levels, and other important blood components accelerates the growth of the industry.
Disposable lancet eliminates the risk of blood transfusion and transmission of infections and thus contributes to the growth of the blood lancets industry. Nevertheless, low awareness in developed countries about homecare lancet is expected to hamper the market growth. On the contrary, the favorable regulatory scenario is having a positive effect on the growth of the blood lancets market, thereby generating lucrative opportunities in the near future.
Recently, emerging and re-emerging infectious diseases like coronavirus disease poses a significant threat to public health in countries across the globe. Infectious diseases are the number one cause of morbidity and mortality worldwide. Diagnostics is the first step to treating infectious diseases and eradicating them. There is an urgent need to identify appropriate diagnostic strategies for better treatment of each disease due to the ever-evolving pathogens and emerging new diseases. In addition, effective diagnostic techniques are essential for disease identification and better treatment, as well as population outbreak control.
Based on Type, the market is segmented into Vacuum Blood Lancets, Safety Blood Lancets and Standard Blood Lancets. Based on End Users, the market is segmented into Homecare, Hospitals and Clinics, Blood Banks and other End Users. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Medtronic PLC, Abbott Laboratories, Terumo Corporation, Haemonetics Corporation, Nipro Corporation, Sarstedt AG & Company, F.L. Medical S.r.l., Socorex Isba SA, and PL Medical Co., LLC
Scope of the Study
Market Segmentation:
By Type
- Vacuum Blood Lancets
- Safety Blood Lancets and
- Standard Blood Lancets
By End Users
- Homecare
- Hospitals and Clinics
- Blood Banks and
- other End Users
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Becton, Dickinson and Company
- Medtronic PLC
- Abbott Laboratories
- Terumo Corporation
- Haemonetics Corporation
- Nipro Corporation
- Sarstedt AG & Company
- F.L. Medical S.r.l.
- Socorex Isba SA
- PL Medical Co., LLC
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Global Blood Lancets Market by Type
Chapter 4. Global Blood Lancets Market by End Users
Chapter 5. Global Blood Lancets Market by Region
Chapter 6. Company Profiles
Companies Mentioned
- Becton, Dickinson and Company
- Medtronic PLC
- Abbott Laboratories
- Terumo Corporation
- Haemonetics Corporation
- Nipro Corporation
- Sarstedt AG & Company
- F.L. Medical S.r.l.
- Socorex Isba SA
- PL Medical Co., LLC
Methodology
LOADING...
